This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/7911733.stm
The article has changed 6 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
Vaccine pulled over bacteria fear | Vaccine pulled over bacteria fear |
(about 2 hours later) | |
Thousands of doses of the meningitis C vaccine have been withdrawn by the manufacturer Novartis following fears of contamination. | |
It is understood that the move was taken after samples from two batches were found to contain a bacterium. | It is understood that the move was taken after samples from two batches were found to contain a bacterium. |
The government's medicines agency said contaminated vaccine had not been distributed to the UK and the move was "entirely precautionary". | |
And there is "no reason" for UK children to be at any risk, it added. | |
Novartis said it was "committed to being a safe and reliable provider". | Novartis said it was "committed to being a safe and reliable provider". |
Some 21,000 doses in total have been removed from the shelves. | Some 21,000 doses in total have been removed from the shelves. |
The recalled batches of the Menjugate Kit, which were manufactured in Italy, had passed safety checks before leaving the factory to be transported by road to the UK. | |
But a small number of samples transported to another country by air, were later found to be contaminated with staphylococcus aureus bacteria. | |
Immunisation | |
The meningitis C vaccine is one of the routine immunisations in childhood, with the first doses normally given when a child is 3 and 4 months old. | |
A spokeswoman for the Medicines and Healthcare products Regulatory Agency said: "The tested samples that failed the sterility test were part of a non-routine study undertaken by the company and were not part of the UK market product." | A spokeswoman for the Medicines and Healthcare products Regulatory Agency said: "The tested samples that failed the sterility test were part of a non-routine study undertaken by the company and were not part of the UK market product." |
Dr Ged Lee, from the MHRA, stressed that the move was a precautionary one and that none of the samples that had come to the UK had been contaminated. | Dr Ged Lee, from the MHRA, stressed that the move was a precautionary one and that none of the samples that had come to the UK had been contaminated. |
He said: "The batch that was contaminated I can reassure you was not distributed into the UK and I can also reassure parents that the product that has been used in the UK has passed all the necessary quality standards and is perfectly safe." | He said: "The batch that was contaminated I can reassure you was not distributed into the UK and I can also reassure parents that the product that has been used in the UK has passed all the necessary quality standards and is perfectly safe." |
The Department of Health reiterated that the recall was a precautionary measure and added that anyone who was concerned after taking the vaccine should contact their GP or NHS Direct. |